01 January 2002
Intracerebroventricular administration of bacterial lipopolysaccharide prevents the development of acute experimental pancreatitis in the rat.
Anna Leja, Ryszard Sendur, Katarzyna Nawrot, Joanna Bonior, Jolanta Jaworek, Jerzy Stachura, Wiesław Pawlik, Stanisław KonturekMed Sci Monit 2002; 8(4): BR136-143 :: ID: 420879
Abstract
BACKGROUND: Lipopolysaccharides (LPS) are responsible for septic shockbut low doses of LPS reduce pancreatic damage produced by caerulein-induced pancreatitis (CIP) in rats.Leptin, produced by adipocytes attenuates the severity of CIP. The aim of this study was to evaluatethe effect of intracerebroventricular (i.c.v.) administration of LPS on CIP and plasma leptin level andto investigate the involvement of sensory nerves (SN) in the effects of LPS on CIP. MATERIAL/METHODS:CIP was produced by subcutaneous (s.c.) infusion of caerulein (25 Kg/kg) to conscious rats. SN were deactivatedwith capsaicin (100 mg/kg s.c.). LPS (0.2, 2, or 20 Kg/rat) were applied to the right cerebral ventricle30 min prior to CIP. RESULTS: CIP was manifested by an increase in plasma levels of amylase, lipase,leptin and an anti-inflammatory interleukin 10 (IL-10), (by 400%, 1000%, 700% and 50%, respectively),confirmed by histological examination and accompanied by 40% reduction in pancreatic blood flow. Pretreatmentof CIP rats with i.c.v. LPS resulted in significant reduction of CIP accompanied by dose-dependent increasein plasma levels of leptin and IL-10. Deactivation of SN, which by itself failed to affect CIP, completelyreversed the beneficial effects of i.c.v. administration of LPS on CIP and reduced plasma leptin andIL-10 concentrations. CONCLUSIONS: Pretreatment with LPS given i.c.v. prevents the development of caerulein-inducedpancreatitis through the activation of SN and though the release of leptin.
Keywords: Adipocytes, Afferent Pathways, amylases, Caerulein, Capsaicin, Comparative Study, Escherichia coli, Injections, Intraventricular, Interleukin-10, Leptin, Lipase, Neurons, Afferent, Rats, Wistar, Sympathectomy, Chemical
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952